Literature DB >> 10710784

Gene therapy setback.

T Beardsley.   

Abstract

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2000        PMID: 10710784     DOI: 10.1038/scientificamerican0200-36

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  7 in total

1.  Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review).

Authors:  Lena J Gamble; Anton V Borovjagin; Qiana L Matthews
Journal:  Exp Ther Med       Date:  2010-03       Impact factor: 2.447

2.  Mesenchymal stem cells as a gene delivery vehicle for successful islet transplantation.

Authors:  Hao Wu; Wenli Lu; Ram I Mahato
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

3.  Conflict of interest.

Authors:  C Ronald MacKenzie; Bruce N Cronstein
Journal:  HSS J       Date:  2006-09

4.  Identification of novel superior polycationic vectors for gene delivery by high-throughput synthesis and screening of a combinatorial library.

Authors:  Mini Thomas; James J Lu; Chengcheng Zhang; Jianzhu Chen; Alexander M Klibanov
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

5.  Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC).

Authors:  Xiao-Jun Lin; Qi-Jiong Li; Xiang-Ming Lao; Han Yang; Sheng-Ping Li
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

6.  Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.

Authors:  T Reid; E Galanis; J Abbruzzese; D Sze; J Andrews; L Romel; M Hatfield; J Rubin; D Kirn
Journal:  Gene Ther       Date:  2001-11       Impact factor: 5.250

Review 7.  Intravascular adenoviral agents in cancer patients: lessons from clinical trials.

Authors:  Tony Reid; Robert Warren; David Kirn
Journal:  Cancer Gene Ther       Date:  2002-12       Impact factor: 5.987

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.